Literature DB >> 4338115

Deficient renal cyclic adenosine 3'-5' monophosphate production in nephrogenic diabetes insipidus.

M P Fichman, G Brooker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4338115     DOI： 10.1210/jcem-35-1-35

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

1.  Symptomatic hyponatraemia associated with tolbutamide therapy.

Authors:  B A Darlow
Journal:  Postgrad Med J       Date:  1977-04       Impact factor: 2.401

Review 2.  Adenyl cyclase.

Authors:  M L Steer
Journal:  Ann Surg       Date:  1975-11       Impact factor: 12.969

3.  Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.

Authors:  W S Uttley; B Atkinson; A Adams; D Shirling
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

Review 4.  Diabetes insipidus. Current treatment recommendations.

Authors:  J R Seckl; D B Dunger
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

5.  Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.

Authors:  A E Broadus; J E Mahaffey; F C Bartter; R M Neer
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

6.  Temperature sensitivity of cyclic AMP production and catecholamine-induced refractoriness in a rat astrocytoma cell line.

Authors:  G A Nickols; G Brooker
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

Review 7.  The impact of peptide hormone receptor research on clinical medicine.

Authors:  T F Davies
Journal:  J R Coll Physicians Lond       Date:  1978-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.